SIRT5 and type 1 diabetes mellitus: In this study, we investigated whether partially disrupting NAMPT-mediated NAD+ biosynthesis or deleting SIRT3/SIRT5 would accelerate early neuroretinal dysfunction in the STZ-induced mouse model of type 1 diabetes.